Inventage Lab will be attending the Global Drug Delivery & Formulation (DDF) Summit 2026, taking place May 18–20, 2026 in Berlin, Germany.
The Global DDF Summit is a premier international event dedicated to the latest advances in drug delivery and formulation science, bringing together researchers, developers, and business development professionals from across the pharmaceutical and biotech industries. The summit provides a focused platform for in-depth discussions on next-generation delivery technologies, formulation strategies, and cross-sector collaboration.
Inventage Lab is a publicly listed, clinical-stage biotech headquartered in South Korea, developing proprietary microfluidic-based drug delivery platforms. Our portfolio includes DrugFluidic®, a platform for long-acting injectable (LAI) formulations of small molecules and peptides; BioFluidic™, designed to optimize subcutaneous delivery of antibodies and protein therapeutics; and GeneFluidic®, an LNP-based delivery platform for nucleic acid therapeutics. Each platform is engineered to overcome the limitations of conventional formulations and to maximize the pipeline value of our global partners.
At the Global DDF Summit 2026, Inventage Lab will be available for meetings to explore co-development, licensing, and CDMO partnership opportunities across oncology, metabolic disease, neurology, and CNS indications. We welcome inquiries from pharma and biotech companies seeking differentiated formulation technologies to advance their global pipelines.
